Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI) Financial Statements


Puma Biotechnology Financial Overview

Puma Biotechnology's market cap is currently ―. The company's EPS TTM is $0.321; its P/E ratio is 13.71; Puma Biotechnology is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 72.18M$ 56.12M$ 54.57M$ 46.79M$ 65.67M
Gross Profit$ 47.85M$ 42.83M$ 42.71M$ 65.99M$ 48.84M
EBIT$ 16.16M$ 9.35M$ 5.64M$ 4.86M$ 9.81M
EBITDA$ 19.05M-$ 0.00$ 7.74M$ 12.02M
Net Income Common Stockholders$ 12.27M$ 5.80M$ 2.13M$ 98.22M$ -5.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 95.94M$ 85.03M$ 74.44M$ 71.22M$ 81.07M
Total Assets$ 230.53M$ 203.60M$ 200.49M$ 195.24M$ 220.91M
Total Debt$ 111.49M$ 112.22M$ 112.94M$ 113.64M$ 114.28M
Net Debt$ 15.55M$ 27.19M$ 38.50M$ 42.42M$ 33.21M
Total Liabilities$ 177.09M$ 164.86M$ 170.09M$ 169.24M$ 222.06M
Stockholders Equity$ 53.44M$ 38.74M$ 30.40M$ 25.85M$ 21.61M
Cash Flow-
Free Cash Flow$ 10.41M--$ -9.86M$ 7.68M
Operating Cash Flow$ 10.46M$ 10.62M-$ 2.64M$ 7.68M
Investing Cash Flow$ -8.17M$ 11.18M-$ -17.45M$ -11.87M
Financing Cash Flow----$ 2.43M
Currency in USD

Puma Biotechnology Earnings and Revenue History

Puma Biotechnology Debt to Assets

Puma Biotechnology Cash Flow

Puma Biotechnology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis